The latest update is out from Sight Sciences ( (SGHT) ).
On March 5, 2025, Sight Sciences reported its financial results for the fourth quarter and full year 2024, revealing a slight revenue decline for the year but a significant reduction in cash usage and operating expenses. The company also announced a new financial guidance for 2025, anticipating a revenue decline due to changes in Medicare coverage for certain procedures, while continuing to focus on strategic initiatives and market access opportunities for its products.
More about Sight Sciences
Sight Sciences, Inc. is an eyecare technology company focused on developing and commercializing innovative interventional technologies to improve the standard of care in the eyecare industry.
YTD Price Performance: -31.01%
Average Trading Volume: 239,158
Technical Sentiment Consensus Rating: Buy
Current Market Cap: $125.4M
For detailed information about SGHT stock, go to TipRanks’ Stock Analysis page.
Trending Articles:
Questions or Comments about the article? Write to editor@tipranks.com